• Drug Coverage
  • Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Safety & Recalls
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Georgia passes open insurance law, no one cares

Article

A law that took effect in December would allow insurers to sell policies across state lines has no takers. The law was supposed to allow the free market to lower prices and increase choice.

A law that took effect in December last year would allow insurers to sell policies across state lines has no takers. The law was supposed to allow the free market to lower prices and increase choice, but insurers may be waiting for the Supreme Court to decide the constitutionality of the Affordable Care and Patient Protection Act before adjusting their business model.

The Atlanta Journal-Constitution quotes Georgia Insurance Commissioner Ralph Hudgens as being “dumbfounded” by the lack of interest in the law that could allow Georgia consumers to buy health plans that meet the less stringent requirements of other states.

Rep. Matt Ramsey, R-Peachtree City, who sponsored the legislation, blames the apparent lack of interest on the wait-and-see attitude that the Supreme Court case is having on healthcare reform. Insurers may be reluctant to overhaul their business processes before the expected ruling in June.

The law applies to the individual market, not to Georgians who are insured through their employers. If the law plays out as intended, it would allow an insurer to offer any other state plan to Georgia’s private market customers.

The Atlanta Journal-Constitution says four other states have enacted such a laws, but they have not produced any new insurance products either.

Go back to the Managed Healthcare Executive eNews newsletter.

Related Videos
Video 9 -"Overcoming Implementation Barriers for Digital Therapeutics Adoption"
Video 6 - "Failing to Reach Ideal Diabetes Care: Equitable Doesn’t Mean Equal"
Video 5 - "Revising Diabetes Outcome Measures"
Video 6 - "Navigating Insurance Coverage for Prescription Digital Therapeutics"
Video 5 - "FDA Approval Pathway for Prescription Digital Therapeutics"
Video 8 - "Gaps in Evidence Generation for Digital Therapeutics"
Video 7 - "Adoption Lessons For Payers"
Video 10 - "Managing Self Care"
Video 3 - "Embracing and Improving Access to Technology Tools"
Related Content
© 2024 MJH Life Sciences

All rights reserved.